CD133+ cells isolated from CRC cell populations have been shown to mimic properties of CRC cancer stem cells and CD44+ cells exhibit enhanced tumorigenicity and cell proliferation in CRC [35, 36]. This evidence concerns the gene CD44 and cancer.